iifl-logo-icon 1
iifl-logo-icon 1
iifl-logo-icon 1
Home

Krsnaa Diagnostics Ltd Board Meeting

₹677.6
(-1.41%)
Jul 5, 2024|03:32:05 PM

Krsnaa Diagnost. CORPORATE ACTIONS

07/07/2023calendar-icon
06/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting18 May 202410 May 2024
Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on March 31 2024 and Recommendation of Final Dividend If Any for year ended March 31 2024. Outcome of Board Meeting held on May 18, 2024, Considering and approving the Audited Standalone and Consolidated Financial Results of the Company for Quarter and Year ended March 31, 2024 and other matters. (As Per BSE Announcement Dated on: 18/05/2024)
Board Meeting12 Feb 20241 Feb 2024
Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday February 12 2024 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31 2023. Details regarding Grant of ESOPs. Intimation of Proposed formation of a Wholly owned Subsidiary Company. (As Per BSE Announcement Dated on 13.02.2024) Outcome of Board Meeting held on February 12, 2024, Considering and approving the Unaudited Standalone and Consolidated Financial Results of the Company for Quarter and Nine Months ended December 31, 2023 and other matters. Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Appointment of Chief Executive Officer of the Company. (As per BSE Announcement Dated on 12/02/2024)
Board Meeting3 Nov 202327 Oct 2023
Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday November 03 2023 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30 2023. Outcome of Board Meeting held on November 03, 2023 inter-alia approved the Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2023. Unaudited Financial Results for quarter and half year ended September 30, 2023. (As Per BSE Announcement dated on 03.11.2023)
Board Meeting12 Aug 20235 Aug 2023
Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday August 12 2023 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2023. Outcome of Board Meeting (As per BSE Announcement Dated on 12/08/2023)

Krsnaa Diagnost.: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

QUICKLINKS FOR Krsnaa Diagnostics Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.